The Era of Covid-19; Its’ Impact on Cancer Patient Experience in Southwest Nigeria

Download Article

DOI: 10.21522/TIJPH.2013.09.04.Art018

Authors : Aisagbonhi Henry Osaro, Daniel Olusoji James, Esther Ajakaiye A, Ogunyemi A.A, Adaraloye J.O, Odewabi A.O, Adenuga J.O, Adegbuyi S.O., Adetogun T.A, Ofomola Harlims, Orisade Joel


Patients have developed a well-informed sense of validation concerning maintaining hygiene standards. The pandemic, somehow in disguise, presented the valuable perspective of life reflection and gratitude. The attitude of a majority of patients engaged was immensely that of a deep reflection of the privilege of having access to early diagnosis, treatment, and adequate support. However, the complaints of the past, knowing that they are alive and have hope to keep fighting on with gratitude and sense of acceptance. However, they wished that the experience of the social media – health engagement platform should continue as it provided a good level of the bridge of gap of information. The cost of treatment remains a major concern as it largely translates to possible dropout from treatment courses for most cancer patients who can’t afford the current cost. The concerns of the cancer patients and survivors during and after the covid-19 pandemic are similarly a concern to public health professionals worldwide. The need to aid their return to routine health care services is more important and therefore requires an urgent reorganization of cancer management services. An urgent intervention should be focused on patient re-orientation /pandemic control, staff training and retraining, awareness campaign, screening and result accessibility, special pandemic services, amongst others. The outcome reflected a very huge level of poor cancer patient experience in the public cancer treatment centres, while the reverse is the case with the private cancer treatment centres. This can be managed if an urgent intervention as proffered is implemented.

Keywords: Cancer, Coronavirus, Covid-19, Cancer screening, Cancer treatment, Patient experience.


[1] World health organization 2020. WHO coronavirus disease (covid-19) dashboard. Accessed Aug. 21, 2021.

[2] Dong Shuang, Luo Chenggang, Hu Xuebo, Zhang Jing, Cai Qian, Qian Yu, Ran Fengming, Ou Wuling, Wang Jun, Huang Qing, Ren Tianhua, Han Guang, Zhang Feng, Wei Wei, Liang Xinjun, Xu Huiting, Wang Sheng, Shi Lulu, Wei Shaozhong, Hu Sheng. (2020). Expert Consensus for Treating Cancer Patients During the Pandemic of SARS-CoV-2. Frontiers in Oncology. 10, 2020;1555. Doi: 10.3389/fonc.2020.01555.

[3] Coronado, A.C.; Tran, K.; Chadder, J.; Niu, J.; Fung, S.; Louzado, C.; Rahal, R. in collaboration with the System Performance Steering Committee and the Technical Working Group (2017). The Experience of Patients with Cancer during Diagnosis and Treatment Planning: A Descriptive Study of Canadian Survey Results. Curr. Oncol. 2017, 24, 332-337.

[4] Bailey C, Black JRM, Swanton C. (2020). Cancer Research: The Lessons to Learn from COVID-19. Cancer Discov. 2020 Sep;10(9):1263-1266. doi: 10.1158/2159-8290.CD-20-0823. Epub 2020 Jul 15. PMID: 32669285.

[5] Franz Geisslinger, Angelika M. Vollmar and Karin Bartel. (2020). Pharmaceuticals 2020, 13, 143; doi:10.3390/ph13070143. Accessed june. 21, 2021.

[6] Kaufman HW, Chen Z, Niles J, Fesko Y (2020). Changes in the Number of US Patients with Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw Open. 2020;3(8): e2017267.

[7] Al-Shamsi H O, Alhazzani W, Alhurayi A (2020). A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) Pandemic: An International collaborative group. Oncologist 2020;25(6); e936-e945).

[8] Langarizadeh M, Tabatabaei MS, Tavakol K, (2017). Telemental Health Care, an Effective Alternative to Conventional Mental Care: A Systematic Review. Acta Inform Med 2017; 25:240.

[9] Bouanani N, Bendari M, Naim A, (2020). Managing cancer center during the SARS-COVID -19 Pandemic. Morocan experience. Asian Pac J cancer care 2020; 5(S1):219-223.

[10] Villian P, Carvalho A. L, Lucas E, (2021) Cross-sectional survey of the impact of the covid-19 pandemic on cancer screening programs in selected low- and middle-income countries; study from the IARC COVID-19. Impact study group. Int.J cancer 2021: 149, 97-107.

[11] Zhaoya Gao, Yong Yang, Changmin Dmg, pengfei niu, wenshang huang, fuming lei, jin gu, (2020). Oncologist perspective: when Cancer encounters COVID-19. The oncologist 2020:25:25:61423.

[12] Kamboj M., Sepkowitz KA, (2009). Nocosomial infections in patients with cancer Lancet Oncol. 2009.

[13] Kristof Nemeth, Loannis Nikolopoulos, Ali Reza Mani, (2020). Scooping review on the prevalence of Cancer in COVID-19 Patients. BJS 2020; 107: e456-e457.

[14] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang, (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected Pneumonia in Wuhan China JAMA 2020; 323: 1061 -1069.

[15] Epidemiology Group of emergency response mechanism of new coronavirus Pneumonia; Analysis of epidemiological characteristics of new coronavirus Pneumonia.

[16] Sharma A. Malviya R, Kumar V, Gupta R, Awasthi R. (2020). Severity and Risk of Covid-19 in cancer patients: An Evidence-based learning, dermatologic therapy 2020;33; e13778;

[17] Uzzo RG, Kutikov A, Geymsman DM, (2019). Coronavirus disease 2019 (COVID-19); Cancer during the pandemic. Accessed on May 23, 2021.

[18] World health organization, primary health care on the road to universal health coverage: 2019, global monitoring, Report, Geneva WHO: 2019. Accessed June. 21, 2021.

[19] Beddoe AM. (2019). Elimination of cervical cancer: challenges for developing countries. E. cancer medical science. 2019:13:975.

[20] Henry A. O and Mgbeafuluba I. C. (2018). Awareness and Practice of Cervical Cancer Screening and Human Papilloma Virus Vaccination (HPV) Uptake among Female Staff in Private Tertiary Hospital in Lagos Nigeria Texila International Journal of Public Health Volume 6, Issue 1, Feb 2018.